News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Quirk Gerald E
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2022 |
4
| Quirk Gerald E (Chief Legal Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 45,000 restricted stock units
@ $0 |
|
| 02/19/2021 |
4
| Quirk Gerald E (Chief Legal & Admin. Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 94,000 options to buy
@ $11.41, valued at
$1.1M
|
|
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2018 |
4
| Quirk Gerald E (Chief Legal Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 75,000 options to buy
@ $10.09, valued at
$756.8k
Granted 11,666 options to buy
@ $13.3, valued at
$155.2k
|
|
| 02/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/29/2016 |
4
| Quirk Gerald E (Chief Legal Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc. |
| 12/17/2015 |
4
| Quirk Gerald E (General Counsel, Executive VP) has filed a Form 4 on Tokai Pharmaceuticals Inc|
Txns:
| Granted 62,000 options to buy
@ $9.65, valued at
$598.3k
|
|
| 05/28/2015 |
4
| Quirk Gerald E (General Counsel, Executive VP) has filed a Form 4 on Tokai Pharmaceuticals Inc|
Txns:
| Granted 214,605 options to buy
@ $10.81, valued at
$2.3M
|
|
| 01/09/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/07/2011 |
4
| Quirk Gerald E (VP,Cor. Affairs & Gnrl Counsel) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 9,828 options to buy
@ $5.94, valued at
$58.4k
|
|
| 01/07/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|